News18 » Videos » News18 Shorts

CSIR In Search Of New Combination Drugs To Cure COVID-19 Patients

Jun 24, 2020 05:17 PM IST India India
Share

Even as the country’s drug regulator has approved Glenmark’s FabiFlu, the generic version of antiviral drug Favipiravir, CSIR (Council of Scientific and Industrial Research) and Cipla will carry out a larger, multi-centre clinical trial of the drug to check its efficacy and safety among Covid-19 patients.

Loading